Cite
HARVARD Citation
Cremolini, C. et al. (2019). Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial. European journal of cancer. pp. 175-182. [Online].